Prudential Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.2M Buy
61,317
+3,768
+7% +$1.98M 0.04% 309
2025
Q1
$36.5M Sell
57,549
-1,485
-3% -$942K 0.05% 268
2024
Q4
$42.1M Sell
59,034
-10,529
-15% -$7.5M 0.06% 244
2024
Q3
$73.1M Sell
69,563
-5,322
-7% -$5.59M 0.1% 173
2024
Q2
$78.7M Sell
74,885
-1,077
-1% -$1.13M 0.12% 158
2024
Q1
$73.1M Sell
75,962
-1,022
-1% -$984K 0.1% 184
2023
Q4
$66.6M Sell
76,984
-15,201
-16% -$13.1M 0.1% 188
2023
Q3
$75.9M Sell
92,185
-1,495
-2% -$1.23M 0.12% 165
2023
Q2
$67.3M Sell
93,680
-11,501
-11% -$8.26M 0.1% 189
2023
Q1
$71.2M Sell
105,181
-7,198
-6% -$4.88M 0.11% 178
2022
Q4
$81.1M Sell
112,379
-6,215
-5% -$4.48M 0.14% 155
2022
Q3
$81.7M Sell
118,594
-1,806
-2% -$1.24M 0.14% 146
2022
Q2
$71.7M Sell
120,400
-18,466
-13% -$11M 0.11% 179
2022
Q1
$97M Sell
138,866
-86,956
-39% -$60.7M 0.13% 167
2021
Q4
$146M Sell
225,822
-9,345
-4% -$6.03M 0.18% 121
2021
Q3
$142M Buy
235,167
+66,742
+40% +$40.4M 0.2% 107
2021
Q2
$94.1M Sell
168,425
-3,137
-2% -$1.75M 0.13% 158
2021
Q1
$81.2M Buy
171,562
+81,374
+90% +$38.5M 0.12% 163
2020
Q4
$43.6M Sell
90,188
-108,921
-55% -$52.6M 0.07% 248
2020
Q3
$111M Buy
199,109
+18,806
+10% +$10.5M 0.21% 109
2020
Q2
$112M Buy
180,303
+69,607
+63% +$43.4M 0.21% 99
2020
Q1
$54.1M Sell
110,696
-27,113
-20% -$13.2M 0.12% 166
2019
Q4
$51.7M Sell
137,809
-10,135
-7% -$3.81M 0.08% 261
2019
Q3
$41M Sell
147,944
-79,738
-35% -$22.1M 0.06% 328
2019
Q2
$71.3M Buy
227,682
+149,119
+190% +$46.7M 0.11% 185
2019
Q1
$32.3M Sell
78,563
-13,730
-15% -$5.64M 0.05% 395
2018
Q4
$34.5M Buy
92,293
+8,131
+10% +$3.04M 0.06% 342
2018
Q3
$34M Sell
84,162
-950
-1% -$384K 0.05% 408
2018
Q2
$29.4M Sell
85,112
-838
-1% -$289K 0.04% 468
2018
Q1
$29.6M Sell
85,950
-42,413
-33% -$14.6M 0.05% 471
2017
Q4
$48.4M Buy
128,363
+3,676
+3% +$1.39M 0.07% 332
2017
Q3
$55.8M Sell
124,687
-12,301
-9% -$5.5M 0.08% 272
2017
Q2
$67.3M Buy
136,988
+30,859
+29% +$15.2M 0.1% 219
2017
Q1
$41.1M Buy
106,129
+1,027
+1% +$398K 0.06% 336
2016
Q4
$38.6M Sell
105,102
-14,700
-12% -$5.4M 0.06% 343
2016
Q3
$48.2M Sell
119,802
-2,229
-2% -$896K 0.08% 271
2016
Q2
$42.6M Sell
122,031
-290
-0.2% -$101K 0.07% 282
2016
Q1
$44.1M Sell
122,321
-191,540
-61% -$69M 0.08% 263
2015
Q4
$170M Buy
313,861
+83,285
+36% +$45.2M 0.31% 62
2015
Q3
$107M Buy
230,576
+29,117
+14% +$13.5M 0.21% 100
2015
Q2
$103M Buy
201,459
+99,615
+98% +$50.8M 0.18% 117
2015
Q1
$46M Sell
101,844
-8,780
-8% -$3.96M 0.08% 270
2014
Q4
$45.4M Buy
110,624
+8,200
+8% +$3.36M 0.08% 263
2014
Q3
$36.9M Sell
102,424
-13,311
-12% -$4.8M 0.07% 292
2014
Q2
$32.7M Buy
115,735
+5,831
+5% +$1.65M 0.06% 329
2014
Q1
$33M Buy
109,904
+11,440
+12% +$3.44M 0.06% 319
2013
Q4
$27.1M Sell
98,464
-1,130
-1% -$311K 0.05% 364
2013
Q3
$31.2M Buy
99,594
+1,075
+1% +$336K 0.07% 296
2013
Q2
$22.2M Buy
+98,519
New +$22.2M 0.05% 374